HROW Q2 2024 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q2 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$49M+46.2% YoY

Gross Profit

$36M74.4% margin

Operating Income

$2M3.1% margin

Net Income

-$6M-13.2% margin

EPS (Diluted)

$-0.18

QoQ Revenue Growth

+41.5%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$307M

Total Liabilities

$248M

Stockholders' Equity

$59M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$49M	$33M	+46.2%
Gross Profit	$36M	$23M	+55.1%
Operating Income	$2M	$2M	-34.9%
Net Income	-$6M	-$4M	-53.1%

Revenue Segments

Other Revenues

$68,000100%